Thailand’s first state-owned contract manufacturing facility for the production of clinical research grade biopharmaceuticals.
National Biopharmaceutical Facility (NBF) was initiated in 2008 under the collaboration between BIOTEC/NSTDA and KMUTT. The facility consists of 2 production suites for microbial fermentation and cell culture with corresponding downstream processing capabilities and an automatic sterile fill and finish line, which were all designed to comply with international GMP standards and biosafety regulations. NBF has also acquired a license from Thai FDA to manufacture drug, vaccine and biologics.